Tessie

RSS

tasipimidine

Authorised
This medicine is authorised for use in the European Union.

Overview

Tessie is a veterinary medicine used for short-term alleviation of situational anxiety and fear in dogs triggered by noise or owner departure.

It contains the active substance tasipimidine.

This EPAR was last updated on 16/02/2022

Authorisation details

Product details
Name
Tessie
Agency product number
EMEA/V/C/005427
Active substance
Tasipimidine sulfate
International non-proprietary name (INN) or common name
tasipimidine
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QN05CM96
Publication details
Marketing-authorisation holder
Orion Corporation
Date of issue of marketing authorisation valid throughout the European Union
16/08/2021
Contact address

Orionintie 1
FI-02200 Espoo
Finland

Product information

Tessie - EMEA/V/C/005427 -

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Other hypnotics and sedatives

Therapeutic indication

Alleviation of situational anxiety and fear in dogs triggered by e.g. travel, noise, owner departure, veterinary visits.

Assessment history

How useful was this page?

Add your rating